{
    "info": {
        "nct_id": "NCT05640245",
        "official_title": "Phase 2, Randomized, Parallel-group, Double-blind, Placebo-controlled Study of Sonelokimab in Patients With Active Psoriatic Arthritis",
        "inclusion_criteria": "1. Participant is ≥18 years of age;\n2. Participant has a confirmed diagnosis of PsA per the 2006 Classification criteria for Psoriatic Arthritis (CASPAR) with symptoms for ≥6 months prior to the Screening Visit;\n3. Participant has active disease (defined by a TJC68 of ≥3 and a SJC66 of ≥3);\n4. Participant has either current active PsO or a dermatologist confirmed history of PsO;\n5. Participant tests negative for rheumatoid factor (RF) at the Screening Visit;\n6. Participant tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit;\n7. Participant must be, in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Participant with known hypersensitivity to sonelokimab or any of its excipients;\n2. Participant with known hypersensitivity to adalimumab or any of its excipients;\n3. Participant who has previously failed on anti-interleukin (IL)-17 therapy;\n4. Participant who has previously failed on anti-tumor necrosis factor alpha (TNFα) therapy;\n5. Participant who has had previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit;\n6. Participant who has a diagnosis of chronic inflammatory conditions other than PsO or PsA;\n7. Participant who has a diagnosis of arthritis mutilans",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "5. Participant tests negative for rheumatoid factor (RF) at the Screening Visit;",
                "criterions": [
                    {
                        "exact_snippets": "Participant tests negative for rheumatoid factor (RF) at the Screening Visit",
                        "criterion": "rheumatoid factor (RF)",
                        "requirement": {
                            "requirement_type": "test result",
                            "expected_value": "negative"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participant tests negative for rheumatoid factor (RF) at the Screening Visit",
                        "criterion": "rheumatoid factor (RF)",
                        "requirement": {
                            "requirement_type": "test result",
                            "expected_value": "negative"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Participant has either current active PsO or a dermatologist confirmed history of PsO;",
                "criterions": [
                    {
                        "exact_snippets": "current active PsO",
                        "criterion": "psoriasis (PsO)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "current active PsO",
                        "criterion": "psoriasis (PsO)",
                        "requirement": {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        }
                    },
                    {
                        "exact_snippets": "dermatologist confirmed history of PsO",
                        "criterion": "psoriasis (PsO)",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "dermatologist confirmed history of PsO",
                        "criterion": "psoriasis (PsO)",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": "dermatologist"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "current active PsO",
                                "criterion": "psoriasis (PsO)",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "current active PsO",
                                "criterion": "psoriasis (PsO)",
                                "requirement": {
                                    "requirement_type": "activity_status",
                                    "expected_value": "active"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "dermatologist confirmed history of PsO",
                                "criterion": "psoriasis (PsO)",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "dermatologist confirmed history of PsO",
                                "criterion": "psoriasis (PsO)",
                                "requirement": {
                                    "requirement_type": "confirmation",
                                    "expected_value": "dermatologist"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "6. Participant tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit;",
                "criterions": [
                    {
                        "exact_snippets": "tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit",
                        "criterion": "anti-cyclic citrullinated peptide (CCP) antibodies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit",
                        "criterion": "anti-cyclic citrullinated peptide (CCP) antibodies",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "at the Screening Visit"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit",
                        "criterion": "anti-cyclic citrullinated peptide (CCP) antibodies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "tests negative for anti-cyclic citrullinated peptide (CCP) antibodies at the Screening Visit",
                        "criterion": "anti-cyclic citrullinated peptide (CCP) antibodies",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "at the Screening Visit"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Participant must be, in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information.",
                "criterions": [
                    {
                        "exact_snippets": "in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information",
                        "criterion": "suitability for adalimumab treatment",
                        "requirement": {
                            "requirement_type": "investigator opinion",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information",
                        "criterion": "suitability for adalimumab treatment",
                        "requirement": {
                            "requirement_type": "meets local product information criteria",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information",
                        "criterion": "suitability for adalimumab treatment",
                        "requirement": {
                            "requirement_type": "investigator opinion",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the opinion of the investigator, a suitable candidate for treatment with adalimumab per approved local product information",
                        "criterion": "suitability for adalimumab treatment",
                        "requirement": {
                            "requirement_type": "meets local product information criteria",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Participant has active disease (defined by a TJC68 of ≥3 and a SJC66 of ≥3);",
                "criterions": [
                    {
                        "exact_snippets": "active disease (defined by a TJC68 of ≥3 and a SJC66 of ≥3)",
                        "criterion": "active disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "TJC68 of ≥3",
                        "criterion": "TJC68 (Tender Joint Count 68)",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    },
                    {
                        "exact_snippets": "SJC66 of ≥3",
                        "criterion": "SJC66 (Swollen Joint Count 66)",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "active disease (defined by a TJC68 of ≥3 and a SJC66 of ≥3)",
                        "criterion": "active disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "TJC68 of ≥3",
                        "criterion": "TJC68 (Tender Joint Count 68)",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    },
                    {
                        "exact_snippets": "SJC66 of ≥3",
                        "criterion": "SJC66 (Swollen Joint Count 66)",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "joints"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Participant has a confirmed diagnosis of PsA per the 2006 Classification criteria for Psoriatic Arthritis (CASPAR) with symptoms for ≥6 months prior to the Screening Visit;",
                "criterions": [
                    {
                        "exact_snippets": "confirmed diagnosis of PsA",
                        "criterion": "psoriatic arthritis diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "confirmed diagnosis of PsA",
                        "criterion": "psoriatic arthritis diagnosis",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "per the 2006 Classification criteria for Psoriatic Arthritis (CASPAR)",
                        "criterion": "CASPAR criteria for Psoriatic Arthritis",
                        "requirement": {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "2006 CASPAR criteria"
                        }
                    },
                    {
                        "exact_snippets": "symptoms for ≥6 months prior to the Screening Visit",
                        "criterion": "duration of PsA symptoms",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "confirmed diagnosis of PsA",
                        "criterion": "psoriatic arthritis diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "confirmed diagnosis of PsA",
                        "criterion": "psoriatic arthritis diagnosis",
                        "requirement": {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "per the 2006 Classification criteria for Psoriatic Arthritis (CASPAR)",
                        "criterion": "CASPAR criteria for Psoriatic Arthritis",
                        "requirement": {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "2006 CASPAR criteria"
                        }
                    },
                    {
                        "exact_snippets": "symptoms for ≥6 months prior to the Screening Visit",
                        "criterion": "duration of PsA symptoms",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "3. Participant who has previously failed on anti-interleukin (IL)-17 therapy;",
                "criterions": [
                    {
                        "exact_snippets": "previously failed on anti-interleukin (IL)-17 therapy",
                        "criterion": "anti-interleukin (IL)-17 therapy",
                        "requirement": {
                            "requirement_type": "prior failure",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "previously failed on anti-interleukin (IL)-17 therapy",
                        "criterion": "anti-interleukin (IL)-17 therapy",
                        "requirement": {
                            "requirement_type": "prior failure",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Participant who has a diagnosis of arthritis mutilans",
                "criterions": [
                    {
                        "exact_snippets": "diagnosis of arthritis mutilans",
                        "criterion": "arthritis mutilans",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "diagnosis of arthritis mutilans",
                    "criterion": "arthritis mutilans",
                    "requirement": {
                        "requirement_type": "diagnosis",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "2. Participant with known hypersensitivity to adalimumab or any of its excipients;",
                "criterions": [
                    {
                        "exact_snippets": "known hypersensitivity to adalimumab",
                        "criterion": "hypersensitivity to adalimumab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known hypersensitivity to ... any of its excipients",
                        "criterion": "hypersensitivity to adalimumab excipients",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "known hypersensitivity to adalimumab",
                        "criterion": "hypersensitivity to adalimumab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known hypersensitivity to ... any of its excipients",
                        "criterion": "hypersensitivity to adalimumab excipients",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "1. Participant with known hypersensitivity to sonelokimab or any of its excipients;",
                "criterions": [
                    {
                        "exact_snippets": "known hypersensitivity to sonelokimab",
                        "criterion": "hypersensitivity to sonelokimab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known hypersensitivity to ... any of its excipients",
                        "criterion": "hypersensitivity to any excipients of sonelokimab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "known hypersensitivity to sonelokimab",
                        "criterion": "hypersensitivity to sonelokimab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known hypersensitivity to ... any of its excipients",
                        "criterion": "hypersensitivity to any excipients of sonelokimab",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Participant who has had previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit;",
                "criterions": [
                    {
                        "exact_snippets": "previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit",
                        "criterion": "previous exposure to biologic agents for PsA",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "agents"
                            }
                        }
                    },
                    {
                        "exact_snippets": "previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit",
                        "criterion": "previous exposure to biologic agents for PsA",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to the Screening Visit"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit",
                        "criterion": "previous exposure to biologic agents for PsA",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "agents"
                            }
                        }
                    },
                    {
                        "exact_snippets": "previous exposure to more than 2 biologic agents of any type to treat PsA prior to the Screening Visit",
                        "criterion": "previous exposure to biologic agents for PsA",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to the Screening Visit"
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "1. Participant is ≥18 years of age;",
                "criterions": [
                    {
                        "exact_snippets": "Participant is ≥18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Participant is \u001e18 years of age",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "4. Participant who has previously failed on anti-tumor necrosis factor alpha (TNFα) therapy;",
                "criterions": [
                    {
                        "exact_snippets": "previously failed on anti-tumor necrosis factor alpha (TNFα) therapy",
                        "criterion": "anti-tumor necrosis factor alpha (TNFα) therapy",
                        "requirement": {
                            "requirement_type": "prior failure",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "previously failed on anti-tumor necrosis factor alpha (TNF\u001f) therapy",
                    "criterion": "anti-tumor necrosis factor alpha (TNF\u001f) therapy",
                    "requirement": {
                        "requirement_type": "prior failure",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "6. Participant who has a diagnosis of chronic inflammatory conditions other than PsO or PsA;",
                "criterions": [
                    {
                        "exact_snippets": "diagnosis of chronic inflammatory conditions other than PsO or PsA",
                        "criterion": "chronic inflammatory conditions (excluding PsO or PsA)",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "diagnosis of chronic inflammatory conditions other than PsO or PsA",
                        "criterion": "chronic inflammatory conditions (excluding PsO or PsA)",
                        "requirement": {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "PsO",
                                "PsA"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}